Tag: angina market analysis

Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.

Angina Market Growth Analysis: How Will Revenue Expand During The Forecast Period?

The market for angina treatments has experienced robust expansion historically and is projected to continue this upward trend. Having reached $11.36 billion in 2025, it’s anticipated to further increase to $12.05 billion by 2026, reflecting a compound annual growth rate of 6.1%. Key factors contributing to this expansion during the previous period included the increasing incidence of cardiovascular ailments, the widespread availability of medications like beta blockers and nitrates, the development of specialized cardiac care facilities within hospitals, a surge in diagnostic procedures, and the overall growth within the cardiology sector.

The

angina

market is projected for considerable expansion over the coming years, reaching an estimated value of $14.84 billion by 2030. This growth trajectory is underpinned by a compound annual growth rate (CAGR) of 5.3%, fueled by several key drivers. These include a heightened demand for tailored cardiovascular treatments, a greater prevalence of minimally invasive cardiac interventions, the increasing integration of digital tools for cardiac health monitoring, the broader implementation of cardiac prevention initiatives, and ongoing progress in the development of new cardiovascular medications. Furthermore, the upcoming period will likely witness significant trends such as a rise in the utilization of multifaceted drug regimens, an increased application of extended-release nitrate formulations, a more pronounced focus on proactive cardiac health management, the diversification of interventional therapeutic avenues, and an elevated commitment to managing patient lifestyles and associated risk factors.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16337&type=smp

Angina Market Demand Drivers: What Is Fueling Industry Growth?

The increasing incidence of heart and blood vessel ailments, encompassing conditions like coronary heart disease, heart failure, and stroke, is anticipated to be a significant catalyst for the expansion of the angina market. This escalating trend in cardiovascular diseases is primarily attributed to an aging global population and a greater susceptibility to controllable risk factors, including unhealthy dietary habits, sedentary lifestyles, and the use of tobacco. Consequently, the heightened occurrence of cardiovascular issues fuels the demand for angina therapies, as these ailments often present with chest pain that necessitates medical intervention for symptom alleviation and the prevention of further complications. Illustrating this, data from the Centers for Disease Control and Prevention indicated a rise in deaths related to cardiovascular diseases in the U.S., climbing from 371,506 in 2022 to 919,032 in 2023. Thus, the growing burden of cardiovascular diseases is directly contributing to the market’s advancement in angina treatments.

Angina Market Segment Landscape: Which Areas Lead Market Development?

The angina market covered in this report is segmented –

1) By Type: Angina Pectoris, Unstable Angina, Prinzmetal Angina, Other Types

2) By Treatment: Lifestyle Changes, Medications, Angioplasty And Stenting, Coronary Bypass Surgery, Other Treatments

3) By Drug Class: Beta Blockers, Nitrates And Calcium Channel Blockers, Angiotensin-Converting Enzyme Inhibitors, Other Drug Classes

4) By Application: Clinics, Hospitals, Other Applications

Subsegments:

1) By Angina Pectoris: Stable Angina, Chronic Stable Angina, Effort-Induced Angina, Variant Or Microvascular Angina

2) By Unstable Angina: Acute Unstable Angina, Pre-Infarction Angina, Rest Angina

3) By Prinzmetal Angina: Vasospastic Angina, Coronary Artery Spasm-Induced Angina, Variant Angina

4) By Other Types: Nocturnal Angina, Post-Infarction Angina, Angina With Silent Myocardial Ischemia, Angina Due To Aortic Stenosis Or Valve Disease

Angina Market Innovation Trends: Which Developments Are Transforming The Industry?

In the landscape of the angina market, leading pharmaceutical entities are actively engaged in the creation of novel therapeutic agents, such as metoprolol tartrate tablets. These advancements aim to deliver more potent and precise interventions for individuals afflicted with coronary artery disease (CAD) and its associated ailments. Metoprolol tartrate tablets represent a widely recognized class of pharmaceuticals employed in the management of diverse cardiac issues, encompassing angina (discomfort in the chest), hypertension (elevated blood pressure), and cardiac insufficiency. To illustrate, in April of 2023, Zydus, a pharmaceutical firm originating from India, secured definitive authorization from the U.S. Food and Drug Administration (US-FDA). This approval empowers Zydus to produce and distribute its generic formulation of Metoprolol Tartrate Tablets USP, available in dosages of 25 mg, 50 mg, and 100 mg. Metoprolol itself functions as a beta-blocker, a medication utilized for a spectrum of cardiovascular concerns, including high blood pressure (hypertension) and chest pain (angina), and is also prescribed to enhance recovery outcomes following a myocardial infarction.

Angina Market Industry Leaders And Market Competition

Major companies operating in the angina market are Pfizer Inc., Bayer AG, AstraZeneca PLC, Merck & Co Inc., Sanofi S.A., Novartis AG, GlaxoSmithKline Plc, Eli Lilly and Company, Amgen Inc., Gilead Sciences Inc., Otsuka Pharmaceutical Co Ltd, Bristol-Myers Squibb Company, Boehringer Ingelheim GmbH, Abbott Laboratories, Daiichi Sankyo Company Ltd, Takeda Pharmaceutical Company Limited, Cipla Limited, Sun Pharmaceutical Industries Ltd, Zydus Cadila Healthcare Ltd, Astellas Pharma Inc., Amarin Corporation, Torrent Pharmaceuticals Ltd

Access The Complete Angina Market Report:

https://www.thebusinessresearchcompany.com/report/angina-global-market-report

Angina Market Regional Analysis: Which Region Leads By Revenue?

North Americawas the largest region in the angina market in 2025. Asia-Pacificis expected to be the fastest-growing region in the forecast period. The regions covered in the angina market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.

Angina Market Growth Analysis: How Will Revenue Expand During The Forecast Period?

The market for angina treatments has experienced robust expansion historically and is projected to continue this upward trend. Having reached $11.36 billion in 2025, it’s anticipated to further increase to $12.05 billion by 2026, reflecting a compound annual growth rate of 6.1%. Key factors contributing to this expansion during the previous period included the increasing incidence of cardiovascular ailments, the widespread availability of medications like beta blockers and nitrates, the development of specialized cardiac care facilities within hospitals, a surge in diagnostic procedures, and the overall growth within the cardiology sector.

The

angina

market is projected for considerable expansion over the coming years, reaching an estimated value of $14.84 billion by 2030. This growth trajectory is underpinned by a compound annual growth rate (CAGR) of 5.3%, fueled by several key drivers. These include a heightened demand for tailored cardiovascular treatments, a greater prevalence of minimally invasive cardiac interventions, the increasing integration of digital tools for cardiac health monitoring, the broader implementation of cardiac prevention initiatives, and ongoing progress in the development of new cardiovascular medications. Furthermore, the upcoming period will likely witness significant trends such as a rise in the utilization of multifaceted drug regimens, an increased application of extended-release nitrate formulations, a more pronounced focus on proactive cardiac health management, the diversification of interventional therapeutic avenues, and an elevated commitment to managing patient lifestyles and associated risk factors.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16337&type=smp

Angina Market Demand Drivers: What Is Fueling Industry Growth?

The increasing incidence of heart and blood vessel ailments, encompassing conditions like coronary heart disease, heart failure, and stroke, is anticipated to be a significant catalyst for the expansion of the angina market. This escalating trend in cardiovascular diseases is primarily attributed to an aging global population and a greater susceptibility to controllable risk factors, including unhealthy dietary habits, sedentary lifestyles, and the use of tobacco. Consequently, the heightened occurrence of cardiovascular issues fuels the demand for angina therapies, as these ailments often present with chest pain that necessitates medical intervention for symptom alleviation and the prevention of further complications. Illustrating this, data from the Centers for Disease Control and Prevention indicated a rise in deaths related to cardiovascular diseases in the U.S., climbing from 371,506 in 2022 to 919,032 in 2023. Thus, the growing burden of cardiovascular diseases is directly contributing to the market’s advancement in angina treatments.

Angina Market Segment Landscape: Which Areas Lead Market Development?

The angina market covered in this report is segmented –

1) By Type: Angina Pectoris, Unstable Angina, Prinzmetal Angina, Other Types

2) By Treatment: Lifestyle Changes, Medications, Angioplasty And Stenting, Coronary Bypass Surgery, Other Treatments

3) By Drug Class: Beta Blockers, Nitrates And Calcium Channel Blockers, Angiotensin-Converting Enzyme Inhibitors, Other Drug Classes

4) By Application: Clinics, Hospitals, Other Applications

Subsegments:

1) By Angina Pectoris: Stable Angina, Chronic Stable Angina, Effort-Induced Angina, Variant Or Microvascular Angina

2) By Unstable Angina: Acute Unstable Angina, Pre-Infarction Angina, Rest Angina

3) By Prinzmetal Angina: Vasospastic Angina, Coronary Artery Spasm-Induced Angina, Variant Angina

4) By Other Types: Nocturnal Angina, Post-Infarction Angina, Angina With Silent Myocardial Ischemia, Angina Due To Aortic Stenosis Or Valve Disease

Angina Market Innovation Trends: Which Developments Are Transforming The Industry?

In the landscape of the angina market, leading pharmaceutical entities are actively engaged in the creation of novel therapeutic agents, such as metoprolol tartrate tablets. These advancements aim to deliver more potent and precise interventions for individuals afflicted with coronary artery disease (CAD) and its associated ailments. Metoprolol tartrate tablets represent a widely recognized class of pharmaceuticals employed in the management of diverse cardiac issues, encompassing angina (discomfort in the chest), hypertension (elevated blood pressure), and cardiac insufficiency. To illustrate, in April of 2023, Zydus, a pharmaceutical firm originating from India, secured definitive authorization from the U.S. Food and Drug Administration (US-FDA). This approval empowers Zydus to produce and distribute its generic formulation of Metoprolol Tartrate Tablets USP, available in dosages of 25 mg, 50 mg, and 100 mg. Metoprolol itself functions as a beta-blocker, a medication utilized for a spectrum of cardiovascular concerns, including high blood pressure (hypertension) and chest pain (angina), and is also prescribed to enhance recovery outcomes following a myocardial infarction.

Angina Market Industry Leaders And Market Competition

Major companies operating in the angina market are Pfizer Inc., Bayer AG, AstraZeneca PLC, Merck & Co Inc., Sanofi S.A., Novartis AG, GlaxoSmithKline Plc, Eli Lilly and Company, Amgen Inc., Gilead Sciences Inc., Otsuka Pharmaceutical Co Ltd, Bristol-Myers Squibb Company, Boehringer Ingelheim GmbH, Abbott Laboratories, Daiichi Sankyo Company Ltd, Takeda Pharmaceutical Company Limited, Cipla Limited, Sun Pharmaceutical Industries Ltd, Zydus Cadila Healthcare Ltd, Astellas Pharma Inc., Amarin Corporation, Torrent Pharmaceuticals Ltd

Access The Complete Angina Market Report:

https://www.thebusinessresearchcompany.com/report/angina-global-market-report

Angina Market Regional Analysis: Which Region Leads By Revenue?

North Americawas the largest region in the angina market in 2025. Asia-Pacificis expected to be the fastest-growing region in the forecast period. The regions covered in the angina market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.

Angina Market Growth Analysis: How Will Revenue Expand During The Forecast Period?

The market for angina treatments has experienced robust expansion historically and is projected to continue this upward trend. Having reached $11.36 billion in 2025, it’s anticipated to further increase to $12.05 billion by 2026, reflecting a compound annual growth rate of 6.1%. Key factors contributing to this expansion during the previous period included the increasing incidence of cardiovascular ailments, the widespread availability of medications like beta blockers and nitrates, the development of specialized cardiac care facilities within hospitals, a surge in diagnostic procedures, and the overall growth within the cardiology sector.

The

angina

market is projected for considerable expansion over the coming years, reaching an estimated value of $14.84 billion by 2030. This growth trajectory is underpinned by a compound annual growth rate (CAGR) of 5.3%, fueled by several key drivers. These include a heightened demand for tailored cardiovascular treatments, a greater prevalence of minimally invasive cardiac interventions, the increasing integration of digital tools for cardiac health monitoring, the broader implementation of cardiac prevention initiatives, and ongoing progress in the development of new cardiovascular medications. Furthermore, the upcoming period will likely witness significant trends such as a rise in the utilization of multifaceted drug regimens, an increased application of extended-release nitrate formulations, a more pronounced focus on proactive cardiac health management, the diversification of interventional therapeutic avenues, and an elevated commitment to managing patient lifestyles and associated risk factors.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16337&type=smp

Angina Market Demand Drivers: What Is Fueling Industry Growth?

The increasing incidence of heart and blood vessel ailments, encompassing conditions like coronary heart disease, heart failure, and stroke, is anticipated to be a significant catalyst for the expansion of the angina market. This escalating trend in cardiovascular diseases is primarily attributed to an aging global population and a greater susceptibility to controllable risk factors, including unhealthy dietary habits, sedentary lifestyles, and the use of tobacco. Consequently, the heightened occurrence of cardiovascular issues fuels the demand for angina therapies, as these ailments often present with chest pain that necessitates medical intervention for symptom alleviation and the prevention of further complications. Illustrating this, data from the Centers for Disease Control and Prevention indicated a rise in deaths related to cardiovascular diseases in the U.S., climbing from 371,506 in 2022 to 919,032 in 2023. Thus, the growing burden of cardiovascular diseases is directly contributing to the market’s advancement in angina treatments.

Angina Market Segment Landscape: Which Areas Lead Market Development?

The angina market covered in this report is segmented –

1) By Type: Angina Pectoris, Unstable Angina, Prinzmetal Angina, Other Types

2) By Treatment: Lifestyle Changes, Medications, Angioplasty And Stenting, Coronary Bypass Surgery, Other Treatments

3) By Drug Class: Beta Blockers, Nitrates And Calcium Channel Blockers, Angiotensin-Converting Enzyme Inhibitors, Other Drug Classes

4) By Application: Clinics, Hospitals, Other Applications

Subsegments:

1) By Angina Pectoris: Stable Angina, Chronic Stable Angina, Effort-Induced Angina, Variant Or Microvascular Angina

2) By Unstable Angina: Acute Unstable Angina, Pre-Infarction Angina, Rest Angina

3) By Prinzmetal Angina: Vasospastic Angina, Coronary Artery Spasm-Induced Angina, Variant Angina

4) By Other Types: Nocturnal Angina, Post-Infarction Angina, Angina With Silent Myocardial Ischemia, Angina Due To Aortic Stenosis Or Valve Disease

Angina Market Innovation Trends: Which Developments Are Transforming The Industry?

In the landscape of the angina market, leading pharmaceutical entities are actively engaged in the creation of novel therapeutic agents, such as metoprolol tartrate tablets. These advancements aim to deliver more potent and precise interventions for individuals afflicted with coronary artery disease (CAD) and its associated ailments. Metoprolol tartrate tablets represent a widely recognized class of pharmaceuticals employed in the management of diverse cardiac issues, encompassing angina (discomfort in the chest), hypertension (elevated blood pressure), and cardiac insufficiency. To illustrate, in April of 2023, Zydus, a pharmaceutical firm originating from India, secured definitive authorization from the U.S. Food and Drug Administration (US-FDA). This approval empowers Zydus to produce and distribute its generic formulation of Metoprolol Tartrate Tablets USP, available in dosages of 25 mg, 50 mg, and 100 mg. Metoprolol itself functions as a beta-blocker, a medication utilized for a spectrum of cardiovascular concerns, including high blood pressure (hypertension) and chest pain (angina), and is also prescribed to enhance recovery outcomes following a myocardial infarction.

Angina Market Industry Leaders And Market Competition

Major companies operating in the angina market are Pfizer Inc., Bayer AG, AstraZeneca PLC, Merck & Co Inc., Sanofi S.A., Novartis AG, GlaxoSmithKline Plc, Eli Lilly and Company, Amgen Inc., Gilead Sciences Inc., Otsuka Pharmaceutical Co Ltd, Bristol-Myers Squibb Company, Boehringer Ingelheim GmbH, Abbott Laboratories, Daiichi Sankyo Company Ltd, Takeda Pharmaceutical Company Limited, Cipla Limited, Sun Pharmaceutical Industries Ltd, Zydus Cadila Healthcare Ltd, Astellas Pharma Inc., Amarin Corporation, Torrent Pharmaceuticals Ltd

Access The Complete Angina Market Report:

https://www.thebusinessresearchcompany.com/report/angina-global-market-report

Angina Market Regional Analysis: Which Region Leads By Revenue?

North Americawas the largest region in the angina market in 2025. Asia-Pacificis expected to be the fastest-growing region in the forecast period. The regions covered in the angina market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

From Its 2026 Market Size, What Value Is The Angina Market Projected To Reach By 2030?

The angina market has experienced substantial growth in its size over recent years. Projections indicate its expansion from $11.36 billion in 2025 to $12.05 billion by 2026, exhibiting a compound annual growth rate (CAGR) of 6.1%. This historic growth is linked to factors such as the increasing prevalence of cardiovascular diseases, the accessibility of beta blockers and nitrates, the expansion of hospital cardiac care units, a rise in diagnostic testing, and the development of cardiology specialty care.

The angina market is projected to experience robust expansion in the coming years. It is forecast to achieve a size of $14.84 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 5.3%. This anticipated growth is driven by factors such as an increasing demand for individualized cardiovascular treatment, the expanding use of minimally invasive cardiac interventions, the growing adoption of digital cardiac monitoring, the broadening of preventive cardiology initiatives, and advances in cardiovascular drug development. Significant trends identified for the forecast period include the rising acceptance of combination drug therapies, increased application of long-acting nitrates, a concentrated focus on preventive cardiac care, the diversification of interventional treatment alternatives, and an intensified emphasis on lifestyle and risk management.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/angina-global-market-report

Which Key Drivers Are Affecting The Angina Market Development?

The increasing occurrence of cardiovascular diseases is projected to stimulate the expansion of the angina market in the coming years. Cardiovascular diseases are conditions affecting the heart and blood vessels, encompassing ailments like coronary heart disease, heart failure, and stroke. The growing incidence of these diseases is primarily attributable to an aging global population and heightened exposure to preventable risk factors, including inadequate nutrition, sedentary lifestyles, and tobacco consumption. This rise in cardiovascular disease prevalence fuels the need for angina treatments, as these conditions frequently manifest as chest pain requiring medical intervention to alleviate symptoms and prevent complications. For instance, data from October 2024, sourced from the US-based Centers for Disease Control and Prevention, indicates a significant increase in cardiovascular disease deaths, climbing from 371,506 cases in 2022 to 919,032 deaths in 2023. Consequently, the escalating prevalence of cardiovascular diseases is a key factor driving the growth of the angina market.

How Is The Angina Market Segmented Across Different Segment Categories?

The angina market covered in this report is segmented –

1) By Type: Angina Pectoris, Unstable Angina, Prinzmetal Angina, Other Types

2) By Treatment: Lifestyle Changes, Medications, Angioplasty And Stenting, Coronary Bypass Surgery, Other Treatments

3) By Drug Class: Beta Blockers, Nitrates And Calcium Channel Blockers, Angiotensin-Converting Enzyme Inhibitors, Other Drug Classes

4) By Application: Clinics, Hospitals, Other Applications

Subsegments:

1) By Angina Pectoris: Stable Angina, Chronic Stable Angina, Effort-Induced Angina, Variant Or Microvascular Angina

2) By Unstable Angina: Acute Unstable Angina, Pre-Infarction Angina, Rest Angina

3) By Prinzmetal Angina: Vasospastic Angina, Coronary Artery Spasm-Induced Angina, Variant Angina

4) By Other Types: Nocturnal Angina, Post-Infarction Angina, Angina With Silent Myocardial Ischemia, Angina Due To Aortic Stenosis Or Valve Disease

What Trends Are Transforming The Angina Market?

Leading companies active in the angina market are engaged in the development of innovative pharmaceuticals, such as metoprolol tartrate tablets, aiming to deliver more efficacious and targeted therapies for individuals suffering from coronary artery disease (CAD) and related ailments. These metoprolol tartrate tablets represent a medication frequently administered for treating a range of cardiovascular conditions, including angina (chest pain), hypertension (high blood pressure), and heart failure. For instance, in April 2023, Zydus, an India-based pharmaceutical company, obtained final authorization from the United States Food and Drug Administration (US-FDA) to produce and offer its generic form of Metoprolol Tartrate Tablets USP in strengths of 25 mg, 50 mg, and 100 mg. Metoprolol functions as a beta blocker, utilized in the management of various cardiovascular disorders, such as high blood pressure (hypertension) and chest pain (angina), and for improving survival post-heart attack.

Which Organizations Play A Role In The Angina Market Landscape?

Major companies operating in the angina market are Pfizer Inc., Bayer AG, AstraZeneca PLC, Merck & Co Inc., Sanofi S.A., Novartis AG, GlaxoSmithKline Plc, Eli Lilly and Company, Amgen Inc., Gilead Sciences Inc., Otsuka Pharmaceutical Co Ltd, Bristol-Myers Squibb Company, Boehringer Ingelheim GmbH, Abbott Laboratories, Daiichi Sankyo Company Ltd, Takeda Pharmaceutical Company Limited, Cipla Limited, Sun Pharmaceutical Industries Ltd, Zydus Cadila Healthcare Ltd, Astellas Pharma Inc., Amarin Corporation, Torrent Pharmaceuticals Ltd

Get The Full Angina Market Report:

https://www.thebusinessresearchcompany.com/report/angina-global-market-report

Which Region Holds The Highest Market Share In The Angina Market?

North America was the largest region in the angina market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the angina market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Angina Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/angina-global-market-report

Browse Through More Reports Similar to the Global Angina Market 2026, By The Business Research Company

Angio Suites Market Report 2026

https://www.thebusinessresearchcompany.com/report/angio-suites-global-market-report

Angina Pectoris Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/angina-pectoris-drugs-global-market-report

Angina Pectoris Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/angina-pectoris-drugs-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

From Its 2026 Market Size, What Value Is The Angina Market Projected To Reach By 2030?

The angina market has experienced substantial growth in its size over recent years. Projections indicate its expansion from $11.36 billion in 2025 to $12.05 billion by 2026, exhibiting a compound annual growth rate (CAGR) of 6.1%. This historic growth is linked to factors such as the increasing prevalence of cardiovascular diseases, the accessibility of beta blockers and nitrates, the expansion of hospital cardiac care units, a rise in diagnostic testing, and the development of cardiology specialty care.

The angina market is projected to experience robust expansion in the coming years. It is forecast to achieve a size of $14.84 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 5.3%. This anticipated growth is driven by factors such as an increasing demand for individualized cardiovascular treatment, the expanding use of minimally invasive cardiac interventions, the growing adoption of digital cardiac monitoring, the broadening of preventive cardiology initiatives, and advances in cardiovascular drug development. Significant trends identified for the forecast period include the rising acceptance of combination drug therapies, increased application of long-acting nitrates, a concentrated focus on preventive cardiac care, the diversification of interventional treatment alternatives, and an intensified emphasis on lifestyle and risk management.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/angina-global-market-report

Which Key Drivers Are Affecting The Angina Market Development?

The increasing occurrence of cardiovascular diseases is projected to stimulate the expansion of the angina market in the coming years. Cardiovascular diseases are conditions affecting the heart and blood vessels, encompassing ailments like coronary heart disease, heart failure, and stroke. The growing incidence of these diseases is primarily attributable to an aging global population and heightened exposure to preventable risk factors, including inadequate nutrition, sedentary lifestyles, and tobacco consumption. This rise in cardiovascular disease prevalence fuels the need for angina treatments, as these conditions frequently manifest as chest pain requiring medical intervention to alleviate symptoms and prevent complications. For instance, data from October 2024, sourced from the US-based Centers for Disease Control and Prevention, indicates a significant increase in cardiovascular disease deaths, climbing from 371,506 cases in 2022 to 919,032 deaths in 2023. Consequently, the escalating prevalence of cardiovascular diseases is a key factor driving the growth of the angina market.

How Is The Angina Market Segmented Across Different Segment Categories?

The angina market covered in this report is segmented –

1) By Type: Angina Pectoris, Unstable Angina, Prinzmetal Angina, Other Types

2) By Treatment: Lifestyle Changes, Medications, Angioplasty And Stenting, Coronary Bypass Surgery, Other Treatments

3) By Drug Class: Beta Blockers, Nitrates And Calcium Channel Blockers, Angiotensin-Converting Enzyme Inhibitors, Other Drug Classes

4) By Application: Clinics, Hospitals, Other Applications

Subsegments:

1) By Angina Pectoris: Stable Angina, Chronic Stable Angina, Effort-Induced Angina, Variant Or Microvascular Angina

2) By Unstable Angina: Acute Unstable Angina, Pre-Infarction Angina, Rest Angina

3) By Prinzmetal Angina: Vasospastic Angina, Coronary Artery Spasm-Induced Angina, Variant Angina

4) By Other Types: Nocturnal Angina, Post-Infarction Angina, Angina With Silent Myocardial Ischemia, Angina Due To Aortic Stenosis Or Valve Disease

What Trends Are Transforming The Angina Market?

Leading companies active in the angina market are engaged in the development of innovative pharmaceuticals, such as metoprolol tartrate tablets, aiming to deliver more efficacious and targeted therapies for individuals suffering from coronary artery disease (CAD) and related ailments. These metoprolol tartrate tablets represent a medication frequently administered for treating a range of cardiovascular conditions, including angina (chest pain), hypertension (high blood pressure), and heart failure. For instance, in April 2023, Zydus, an India-based pharmaceutical company, obtained final authorization from the United States Food and Drug Administration (US-FDA) to produce and offer its generic form of Metoprolol Tartrate Tablets USP in strengths of 25 mg, 50 mg, and 100 mg. Metoprolol functions as a beta blocker, utilized in the management of various cardiovascular disorders, such as high blood pressure (hypertension) and chest pain (angina), and for improving survival post-heart attack.

Which Organizations Play A Role In The Angina Market Landscape?

Major companies operating in the angina market are Pfizer Inc., Bayer AG, AstraZeneca PLC, Merck & Co Inc., Sanofi S.A., Novartis AG, GlaxoSmithKline Plc, Eli Lilly and Company, Amgen Inc., Gilead Sciences Inc., Otsuka Pharmaceutical Co Ltd, Bristol-Myers Squibb Company, Boehringer Ingelheim GmbH, Abbott Laboratories, Daiichi Sankyo Company Ltd, Takeda Pharmaceutical Company Limited, Cipla Limited, Sun Pharmaceutical Industries Ltd, Zydus Cadila Healthcare Ltd, Astellas Pharma Inc., Amarin Corporation, Torrent Pharmaceuticals Ltd

Get The Full Angina Market Report:

https://www.thebusinessresearchcompany.com/report/angina-global-market-report

Which Region Holds The Highest Market Share In The Angina Market?

North America was the largest region in the angina market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the angina market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Angina Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/angina-global-market-report

Browse Through More Reports Similar to the Global Angina Market 2026, By The Business Research Company

Angio Suites Market Report 2026

https://www.thebusinessresearchcompany.com/report/angio-suites-global-market-report

Angina Pectoris Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/angina-pectoris-drugs-global-market-report

Angina Pectoris Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/angina-pectoris-drugs-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

From Its 2026 Market Size, What Value Is The Angina Market Projected To Reach By 2030?

The angina market has experienced substantial growth in its size over recent years. Projections indicate its expansion from $11.36 billion in 2025 to $12.05 billion by 2026, exhibiting a compound annual growth rate (CAGR) of 6.1%. This historic growth is linked to factors such as the increasing prevalence of cardiovascular diseases, the accessibility of beta blockers and nitrates, the expansion of hospital cardiac care units, a rise in diagnostic testing, and the development of cardiology specialty care.

The angina market is projected to experience robust expansion in the coming years. It is forecast to achieve a size of $14.84 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 5.3%. This anticipated growth is driven by factors such as an increasing demand for individualized cardiovascular treatment, the expanding use of minimally invasive cardiac interventions, the growing adoption of digital cardiac monitoring, the broadening of preventive cardiology initiatives, and advances in cardiovascular drug development. Significant trends identified for the forecast period include the rising acceptance of combination drug therapies, increased application of long-acting nitrates, a concentrated focus on preventive cardiac care, the diversification of interventional treatment alternatives, and an intensified emphasis on lifestyle and risk management.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/angina-global-market-report

Which Key Drivers Are Affecting The Angina Market Development?

The increasing occurrence of cardiovascular diseases is projected to stimulate the expansion of the angina market in the coming years. Cardiovascular diseases are conditions affecting the heart and blood vessels, encompassing ailments like coronary heart disease, heart failure, and stroke. The growing incidence of these diseases is primarily attributable to an aging global population and heightened exposure to preventable risk factors, including inadequate nutrition, sedentary lifestyles, and tobacco consumption. This rise in cardiovascular disease prevalence fuels the need for angina treatments, as these conditions frequently manifest as chest pain requiring medical intervention to alleviate symptoms and prevent complications. For instance, data from October 2024, sourced from the US-based Centers for Disease Control and Prevention, indicates a significant increase in cardiovascular disease deaths, climbing from 371,506 cases in 2022 to 919,032 deaths in 2023. Consequently, the escalating prevalence of cardiovascular diseases is a key factor driving the growth of the angina market.

How Is The Angina Market Segmented Across Different Segment Categories?

The angina market covered in this report is segmented –

1) By Type: Angina Pectoris, Unstable Angina, Prinzmetal Angina, Other Types

2) By Treatment: Lifestyle Changes, Medications, Angioplasty And Stenting, Coronary Bypass Surgery, Other Treatments

3) By Drug Class: Beta Blockers, Nitrates And Calcium Channel Blockers, Angiotensin-Converting Enzyme Inhibitors, Other Drug Classes

4) By Application: Clinics, Hospitals, Other Applications

Subsegments:

1) By Angina Pectoris: Stable Angina, Chronic Stable Angina, Effort-Induced Angina, Variant Or Microvascular Angina

2) By Unstable Angina: Acute Unstable Angina, Pre-Infarction Angina, Rest Angina

3) By Prinzmetal Angina: Vasospastic Angina, Coronary Artery Spasm-Induced Angina, Variant Angina

4) By Other Types: Nocturnal Angina, Post-Infarction Angina, Angina With Silent Myocardial Ischemia, Angina Due To Aortic Stenosis Or Valve Disease

What Trends Are Transforming The Angina Market?

Leading companies active in the angina market are engaged in the development of innovative pharmaceuticals, such as metoprolol tartrate tablets, aiming to deliver more efficacious and targeted therapies for individuals suffering from coronary artery disease (CAD) and related ailments. These metoprolol tartrate tablets represent a medication frequently administered for treating a range of cardiovascular conditions, including angina (chest pain), hypertension (high blood pressure), and heart failure. For instance, in April 2023, Zydus, an India-based pharmaceutical company, obtained final authorization from the United States Food and Drug Administration (US-FDA) to produce and offer its generic form of Metoprolol Tartrate Tablets USP in strengths of 25 mg, 50 mg, and 100 mg. Metoprolol functions as a beta blocker, utilized in the management of various cardiovascular disorders, such as high blood pressure (hypertension) and chest pain (angina), and for improving survival post-heart attack.

Which Organizations Play A Role In The Angina Market Landscape?

Major companies operating in the angina market are Pfizer Inc., Bayer AG, AstraZeneca PLC, Merck & Co Inc., Sanofi S.A., Novartis AG, GlaxoSmithKline Plc, Eli Lilly and Company, Amgen Inc., Gilead Sciences Inc., Otsuka Pharmaceutical Co Ltd, Bristol-Myers Squibb Company, Boehringer Ingelheim GmbH, Abbott Laboratories, Daiichi Sankyo Company Ltd, Takeda Pharmaceutical Company Limited, Cipla Limited, Sun Pharmaceutical Industries Ltd, Zydus Cadila Healthcare Ltd, Astellas Pharma Inc., Amarin Corporation, Torrent Pharmaceuticals Ltd

Get The Full Angina Market Report:

https://www.thebusinessresearchcompany.com/report/angina-global-market-report

Which Region Holds The Highest Market Share In The Angina Market?

North America was the largest region in the angina market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the angina market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Angina Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/angina-global-market-report

Browse Through More Reports Similar to the Global Angina Market 2026, By The Business Research Company

Angio Suites Market Report 2026

https://www.thebusinessresearchcompany.com/report/angio-suites-global-market-report

Angina Pectoris Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/angina-pectoris-drugs-global-market-report

Angina Pectoris Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/angina-pectoris-drugs-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Is The Market Size Of The Angina Market Expected To Change Between 2026 And 2030?

The angina market has shown strong growth in recent years. It is expected to rise from $11.36 billion in 2025 to $12.05 billion in 2026 at a CAGR of 6.1%. This growth during the historic period is attributed to the increasing prevalence of cardiovascular diseases, availability of beta blockers and nitrates, expansion of cardiac care units in hospitals, higher rates of diagnostic testing, and the growth of cardiology specialty services.

The angina market is expected to witness strong growth over the next few years, reaching $14.84 billion by 2030 at a CAGR of 5.3%. This growth is supported by increasing demand for personalized cardiovascular treatments, wider use of minimally invasive cardiac procedures, rising adoption of digital cardiac monitoring solutions, expansion of preventive cardiology programs, and ongoing advancements in cardiovascular drug development. Major trends include greater use of combination therapies, increased reliance on long-acting nitrates, stronger emphasis on preventive cardiac care, expansion of interventional treatment options, and heightened focus on lifestyle management and risk reduction.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16337&type=smp

Which Major Factors Are Driving The Expansion Of The Angina Market?

The growing prevalence of cardiovascular diseases is anticipated to boost the angina market going forward. Cardiovascular diseases include disorders affecting the heart and blood vessels, such as coronary heart disease, heart failure, and stroke. Their increasing prevalence is mainly driven by aging populations and greater exposure to risk factors like unhealthy diets, physical inactivity, and tobacco use. This rise increases the demand for angina treatments, as these conditions often present with chest pain requiring effective management to prevent complications. For instance, in October 2024, the Centers for Disease Control and Prevention, a US-based public health agency, reported that cardiovascular disease deaths rose from 371,506 in 2022 to 919,032 in 2023. Hence, the rising burden of cardiovascular diseases is supporting the growth of the angina market.

How Is The Angina Market Structured Across Different Segments?

The angina market covered in this report is segmented –

1) By Type: Angina Pectoris, Unstable Angina, Prinzmetal Angina, Other Types

2) By Treatment: Lifestyle Changes, Medications, Angioplasty And Stenting, Coronary Bypass Surgery, Other Treatments

3) By Drug Class: Beta Blockers, Nitrates And Calcium Channel Blockers, Angiotensin-Converting Enzyme Inhibitors, Other Drug Classes

4) By Application: Clinics, Hospitals, Other Applications

Subsegments:

1) By Angina Pectoris: Stable Angina, Chronic Stable Angina, Effort-Induced Angina, Variant Or Microvascular Angina

2) By Unstable Angina: Acute Unstable Angina, Pre-Infarction Angina, Rest Angina

3) By Prinzmetal Angina: Vasospastic Angina, Coronary Artery Spasm-Induced Angina, Variant Angina

4) By Other Types: Nocturnal Angina, Post-Infarction Angina, Angina With Silent Myocardial Ischemia, Angina Due To Aortic Stenosis Or Valve Disease

Which Trends Are Shaping The Future Of The Angina Market?

Major players in the angina market are focusing on developing innovative medications such as metoprolol tartrate tablets to deliver more targeted and effective treatment for patients with coronary artery disease (CAD) and related conditions. These tablets are widely used to manage cardiovascular conditions such as angina, hypertension, and heart failure. For instance, in April 2023, Zydus, an India-based pharmaceutical company, received final approval from the US-FDA to produce and market its generic Metoprolol Tartrate Tablets USP in strengths of 25 mg, 50 mg, and 100 mg. As a beta blocker, metoprolol helps manage high blood pressure and chest pain while improving survival after heart attacks.

Which Major Players Dominate The Angina Market?

Major companies operating in the angina market are Pfizer Inc., Bayer AG, AstraZeneca PLC, Merck & Co Inc., Sanofi S.A., Novartis AG, GlaxoSmithKline Plc, Eli Lilly and Company, Amgen Inc., Gilead Sciences Inc., Otsuka Pharmaceutical Co Ltd, Bristol-Myers Squibb Company, Boehringer Ingelheim GmbH, Abbott Laboratories, Daiichi Sankyo Company Ltd, Takeda Pharmaceutical Company Limited, Cipla Limited, Sun Pharmaceutical Industries Ltd, Zydus Cadila Healthcare Ltd, Astellas Pharma Inc., Amarin Corporation, Torrent Pharmaceuticals Ltd

Read the full angina market report here:

https://www.thebusinessresearchcompany.com/report/angina-global-market-report

Which Region Currently Holds The Largest Share Of The Angina Market?

North America was the largest region in the angina market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the angina market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Angina Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=16337&type=smp

Browse Through More Reports Similar to the Global Angina Market 2026, By The Business Research Company

Angina Pectoris Drugs Global Market Report

https://www.thebusinessresearchcompany.com/report/angina-pectoris-drugs-global-market-report

Angina Pectoris Drugs Global Market Report

https://www.thebusinessresearchcompany.com/report/angina-pectoris-drugs-global-market-report

Angio Suites Global Market Report

https://www.thebusinessresearchcompany.com/report/angio-suites-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model